Predictors of Mortality in Patients with Chronic Heart Failure: Is Hyponatremia a Useful Clinical Biomarker?

BACKGROUND: Chronic heart failure (CHF) is a global health burden. Despite advances in treatment, there remain well-recognised morbidity and mortality. Risk stratification requires the identification and validation of biomarkers, old and new. Hyponatremia has re-emerged as a prognostic marker in CHF...

Descripción completa

Detalles Bibliográficos
Autor principal: Alem, Manal M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7381090/
https://www.ncbi.nlm.nih.gov/pubmed/32765046
http://dx.doi.org/10.2147/IJGM.S260256

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7381090/
https://www.ncbi.nlm.nih.gov/pubmed/32765046
http://dx.doi.org/10.2147/IJGM.S260256

Ejemplares similares